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To Refer or Not to Refer:
General Pediatricians’ Perspectives
on Their Role in Caring for Transgender Youth
Deirdre A. Shires,1,* Ashley Schnaar,2 Maureen D. Connolly,3 and Daphna Stroumsa4
Abstract
Little is known about general pediatricians’ experience and knowledge regarding the care of transgender youth.
We surveyed N = 50 general pediatricians practicing in an integrated Midwest health system. Few respondents
had participated in medical management care for transgender patients, but one-third were willing to do so if
training opportunities were made available. Notably, <60% of respondents were comfortable providing routine
care for transgender youth. At a minimum, pediatricians need the training to feel capable of providing routine
care for transgender pediatric patients. In addition, opportunities for training should be offered to those who are
willing to learn about medical management of transgender youth.
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Introduction
The onset of puberty can lead to worsening gender dys-
phoria for transgender youth and may serve to exacerbate
the health disparities that exist between transgender youth
and their cisgender peers, including increased rates of de-
pression, self-harm, and suicidality.1–3 Currently, there are
two approaches to biomedical intervention during the
peripubertal period to support transgender youth in
affirming their gender identity. For younger patients
who are in the early stages of puberty, the prescription
of gonadotropin-releasing hormone (GnRH) analogues
is recommended to block puberty and the accompanying
development of secondary sex characteristics.3–5 At least
one study has shown that treatment with puberty blockers
can increase general functioning and decrease depressive
symptoms and behavioral problems for transgender
youth.6 For patients in the later stages of puberty, guide-
lines recommend the use of cross-sex hormone therapy
(HT), with or without the continuation of GnRH ana-
logues. The age at which to initiate cross-sex hormones
is an evolving area of debate. Although early guidelines
recommended waiting until age 16, more recent recom-
mendations have allowed for earlier initiation of cross-
gender hormones on a case-by-case basis.5,7
Transgender youth often first identify themselves to a
general pediatrician. As the first medical provider that
transgender youth and their families usually encounter,
it is critical for pediatricians to understand available op-
tions for gender-affirming care and either provide those
services themselves7 or coordinate appropriate referrals
and follow-up. Despite increased visibility of transgender
youth, gaps in the availability of sensitive and appropriate
medical care for this population persist8,9 and guidelines
remain vague about which types of clinicians should diag-
nose, manage, and prescribe puberty blockers and HT for
transgender youth. The role of the primary care provider
in the provision of gender-affirming medications is rap-
idly evolving. However, some general pediatricians may
view these specific services as being outside of their
scope of practice. Currently, data are lacking regarding
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general pediatricians’ experiences, knowledge level, and
comfort with either managing or referring transgender
pediatric patients for endocrine care. Therefore, the aim
of this study was to explore general pediatricians’ experi-
ence with and willingness to manage gender-affirming
medical care (both puberty blockers and cross-sex hor-
mones) for transgender youth. Specifically, we describe
pediatricians’ experiences, willingness to provide care,
barriers and facilitators to providing such care, and
knowledge and opinions related to the care of pediatric
transgender patients.
Materials and Methods
Setting and sample
In April 2017, we conducted a pilot survey of all general
pediatricians (N = 50) practicing in the ambulatory
sites of an integrated health system serving a Midwest
city and its surrounding suburbs. The nearest compre-
hensive gender services program is located*45 miles
away from the health system’s main campus. Eligible
pediatricians were e-mailed a link to a 15-min online
survey housed in RedCAP.10 The survey questions
assessed pediatricians’ experiences, willingness, bar-
riers, facilitators, and knowledge related to the care
of transgender pediatric patients. Respondents were
mailed a $10 gift card. The study was approved by
the Institutional Review Boards at the participating
organizations.
Measures and analysis
Survey questions had either categorical or binary response
values. Sociodemographic questions and knowledge/
opinion questions were categorical and raw frequencies
are reported. Questions related to clinical experiences
(ever initiated GnRH analogues, etc.) were all binary
(yes/no) questions and reported as such. All willingness,
confidence, facilitators, and barrier-related questions
had Likert scale value options (agree, neutral, or disagree).
For these variables, we report the proportion of respon-
dents who indicated that they ‘‘agree.’’ Descriptive statis-
tics were conducted (means/standard deviations and
frequencies) to summarize study data.
Results
Sociodemographics
Respondents (N = 21, 42% response rate) were 81%
female and most (67%) had been in practice for 20
years or more. Half of respondents were white, about
one-third were Asian, and 14% were African American.
Most identified their religion as Christian (66.7%) and
indicated that they were moderately religious (57.1%)
(data not shown). Just about half (52%) of respondents
had provided care for a pediatric patient with gender
dysphoria in the past.
GnRH analogues
None of the respondents had newly prescribed puberty
blockers and only one respondent had refilled a pre-
scription for puberty blockers, only 15% were willing
to refill GnRH analogue prescriptions, and 30% were
willing to learn how to manage GnRH analogues for
transgender pediatric patients if given the opportunity
(Table 1).
Cross-sex HT
None of the respondents had ever initiated cross-sex
HT and one respondent had refilled HT for a pediatric
transgender patient (Table 1). A total of 19.0% of re-
spondents were willing to refill HT and 30% were will-
ing to learn how to prescribe HT for transgender
pediatric patients if given the opportunity.
Referrals for endocrine management
More than half of respondents (55.0%) indicated that
they would always refer to another provider for
GnRH analogues, and a similar proportion (52.4%) in-
dicated that they would always refer a patient for cross-
sex HT (Table 1). More than one-third of respondents
Table 1. General Pediatricians’ Experiences
and Willingness to Provide Endocrine Management
to Transgender Youth (N = 21)
Variable %
Ever cared for transgender pediatric patient 52.4
Ever counseled a patient/family about gender identity issues 72.7
GnRH analogues for transgender youth
Ever initiated 0.0
Ever continued/refilled 4.8
Willing to initiate 0.0
Willing to continue/refill 15.0
Willing to learn how to provide if given opportunity 30.0
HT for transgender youth
Ever initiated 0.0
Ever continued/refilled 4.8
Willing to initiate 4.8
Willing to continue/refill 19.0
Willing to learn how to provide if given opportunity 30.0
Referrals
Ever referred to mental health provider for gender dysphoria
diagnosis letter
45.5
Ever referred to another provider for GnRH analogue or HT 36.4
Would always refer for GnRH analogue 55.0
Would always refer for HT 52.4
GnRH, gonadotropin-releasing hormone; HT, hormone therapy.
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had referred a patient to another provider for hormone
therapy for gender affirmation in the past (36.4%).
Referrals for gender dysphoria confirmation
by a mental health provider
Close to half had referred a transgender pediatric pa-
tient to a mental health provider for confirmation of
gender dysphoria (45.5%).
Factors that facilitate caring for transgender youth
Although more than half of respondents agreed that
they felt capable of providing routine care to transgen-
der youth (57.1%), fewer respondents were familiar
with regimens for GnRH analogues (33.3%) or HT
(23.8%) or confident that they understood the benefits
and risks of these medical management options for
transgender pediatric patients (14.3%) (Table 2).
Barriers to caring for transgender pediatric patients
Reported barriers to caring for transgender youth in-
cluded a lack of time during office visits (61.9%), lack
of familiarity with any guidelines for gender-affirming
care (57.1%), lack of training (61.9%), not knowing men-
tal health providers who could confirm a gender dyspho-
ria diagnosis (35.0%), lack of exposure to transgender
patients (23.8%), and lack of knowledge about transgen-
der patients among medical staff (23.8%) (Table 2).
Knowledge and opinions related to caring
for transgender pediatric patients
In terms of knowledge, half or more respondents indi-
cated that they did not know when puberty blockers
should be initiated (76.2%), when cross-sex HT should
be initiated (80.0%), who can prescribe puberty block-
ers and HT to transgender pediatric patients (60.0%),
whether gender dysphoria is classified as a mental dis-
order (71.4%), or whether children with gender-variant
identities that persist into adolescence develop an adult
transgender identity (50.0%) (Table 3).
Participants were more knowledgeable about psy-
chosocial issues affecting transgender youth; nearly
all of the respondents understood that puberty is a sig-
nificant source of distress for transgender youth
(95.2%). Most also indicated that the statement ‘‘Ini-
tiating social and medical gender transition for pediat-
ric transgender patients has no impact on their risk of
depression’’ was false (85.7%), and most respondents
knew that clinicians were not obligated to disclose a pe-
diatric patient’s gender identity to the parent or guard-
ian if the child did not want the parent to know (61.9%)
(Table 3).
Discussion
This is the first study of which the authors are aware to
assess general pediatricians’ experiences and opinions
about caring for transgender youth, particularly related
to pediatricians’ views on their role in medication
management for this patient population. We found
that very few respondents had initiated or continued
GnRH analogues or HT for a pediatric transgender pa-
tient in the past. About half of respondents indicated
that they would always refer transgender youth for
medical management services. Yet, more than half of
respondents indicated that they did not know what
type of healthcare provider (primary care, psychiatrist,
endocrinologist, etc.) should be providing medical
management for transgender youth. Because general
pediatricians are often the gatekeepers to specialty
care, it is critical that they be knowledgeable about
when and where to refer transgender youth for medical
management services, if the patient requests them.
Only about one-third of participants indicated that
they were willing to learn how to prescribe GnRH an-
alogues or HT if given the opportunity. This divide
may be indicative of current ambiguity regarding the
type of care general pediatricians can and should be
providing for transgender youth and how far this
care extends into gender-affirming treatments. There
is more to be explored regarding the reasons why the
majority of pediatricians were unwilling to learn how
to prescribe HT and GnRH analogues. At a minimum,
our findings illustrate the need for increased training
Table 2. General Pediatricians’ Facilitators and Barriers
Related to Caring for Transgender Youth (N = 21)
Variable %
Facilitators
Feels capable of providing routine medical care
to pediatric transgender patients.
57.1
Familiar with Lupron/GnRH analogue regimens 33.3
Familiar with gender-affirming HT regimen 23.8
Confident in knowledge of the health risks/benefits
of GnRH and gender-affirming HT
14.3
Barriers to caring for transgender youth
Not enough time during office visits to provide gender
transition care
61.9
Not familiar with transition care guidelines 57.1
Lack of training in transgender-specific pediatric care 61.9
Do not know mental health providers who will
assess/confirm gender dysphoria
35.0
Lack of exposure to pediatric transgender patients 23.8
Lack of knowledge about transgender patients among
office staff, medical assistants, and/or nursing staff
23.8
Fear of being sued after irreversible treatments 4.8
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opportunities both during medical training and after
providers are in primary care practice—this is true
for both the minority of pediatricians who expressed
willingness to learn and those who may have reserva-
tions about providing such care.
Regardless, it is imperative that general pediatricians
are willing and confident in their ability to provide rou-
tine care—that is, general prevention, counseling, or
acute care services that would be provided to any pedi-
atric patient—to transgender youth. We found that
<60% of respondents felt capable of providing routine
care to this patient population, with providers citing
barriers to caring for transgender youth such as lack
of time, lack of training, and lack of familiarity with
guidelines. Although respondents demonstrated an un-
derstanding of some of the psychosocial risk factors for
transgender youth and the importance of gender-
affirming medical care, it is clear that more training
and resources are needed for general pediatricians.
Limitations
This was a pilot study in one health system among a
group of mostly Christian, moderately religious provid-
ers with a small sample size and suboptimal response
rate, making generalizability difficult. Lack of power to
conduct multivariate analysis is also a limitation, as we
were unable to explore which provider characteristics,
beliefs, or experiences were associated with willingness
to deliver medical transition care to transgender youth,
such as years of practice experience.
Table 3. General Pediatricians’ Knowledge About Caring for Transgender Youth (N =21)
Question %
1. At what stage should the use of puberty blockers (GnRH) begin in a pediatric patient with persistent gender dysphoria? (check all that apply)
When the patient, parent, and clinician agree 19.0
Tanner stage 1 4.8
Tanner stage 2 9.5
Tanner stage 3 + 4.8
Puberty blockers should never be prescribed to pediatric transgender patients 4.8
I do not know 76.2
2. At what point can the use of cross-sex HT generally begin for a pediatric patient with persistent gender dysphoria? (check all that apply)
When the patient, parent, and clinician agree 10.0
When the patient has used puberty blockers for at least 2 years 5.0
Age 16 if the patient has used puberty blockers for at least 2 years 10.0
Cross-sex HT should never be prescribed to transgender youth 5.0
I do not know 80.0
3. Lupron/GnRH analogue and cross-sex HT can be prescribed to pediatric transgender patients by (check all that apply)
Primary care providers (pediatricians, IM, FM) 25.0
Psychiatrists 15.0
Endocrinologists 40.0
Adolescent medicine providers 30.0
I do not know 60.0
4. Most children whose gender-variant identity persists into adolescence develop an adult transgender identity
True 40.0
False 10.0
I do not know 50.0
5. Puberty is often a source of significant distress for transgender youth
True 95.2
False 0.0
I do not know 4.8
6. Gender dysphoria in youth is classified as a mental disorder
True 4.8
False 23.8
I do not know 71.4
7. Initiating social and medical gender transition for pediatric transgender patients has no impact on their risk of depression
True 9.5
False 85.7
I do not know 4.8
8. It is the clinician’s obligation to disclose a pediatric patient’s gender identity to the patient’s parent/guardian even if the child does not wish for
the parents to know
True 14.3
False 61.9
I do not know 23.8
FM, family medicine; IM, internal medicine.
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Conclusions
This is the first study ofwhich the authors are aware to ex-
plore general pediatricians’ familiarity and comfort with
this clinical area. Given the necessity of access to sensitive
and appropriate pediatric care for transgender youth, gen-
eral pediatricians will likely play an increasingly central
role in the medical transition process for these patients.
However, general pediatricians’ knowledge on this topic
is limited and opportunities for training should be of-
fered to those who are interested and willing to learn
aboutmedicalmanagement for this vulnerable popula-
tion. Because encouraging general pediatricians to take
on medical management for transgender youth could
serve to greatly expand access to such care, more ex-
plicit statements on the role of the general pediatrician
in gender-affirming medical care from professional and
guideline-setting organizations are needed. At a mini-
mum, pediatricians need the exposure and training to
feel capable of providing routine care for transgender pe-
diatric patients, providing support for transgender pa-
tients and their families, and referring or coordinating
medical management care for this population.
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